At a glance
ClinicalIndex Comparison RecordPhase 1Completed· 47 enrolled
Drug / intervention
sildenafil citrate 100 mg CT +2 moredrug
Likely dose
sildenafil citrate 100 mg CTfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Relative Bioavailability Study Between Two Formulations Of Sildenafil Citrate In Healthy Male Subjects, Fasting Dosing, Being The Test Formulation Sildenafil Citrate 100 Mg CT , And The Reference Formulation Sildenafil Citrate 100 Mg Film-Coated Tablets (Viagra®), Both Formulations Manufactured By Laboratórios Pfizer Ltda.
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.·interventional·Posted May 20, 2009·Updated Feb 1, 2021
In Brief
A Phase 1 clinical trial evaluating sildenafil citrate 100 mg CT and Viagra® for Erectile Dysfunction. Completed, enrolled 47 participants across 1 site.
Detailed Summary
The purpose of this study is to perform a relative bioavailability study between two formulations of sildenafil citrate.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsErectile Dysfunction
CountriesBrazil
Collaborators--
Timeline
Phase 1CompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedMay 2009
Enrollment StartJan 2010
Primary CompletionMar 2010
TodayJul 2026
First PostedMay 20, 2009
Enrollment StartJan 1, 2010
Primary CompletionMar 1, 2010
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 17.1 years ago
Interventions
sildenafil citrate 100 mg CTdrug
sildenafil citrate 100 mg CT, single dose without water
sildenafil citrate 100 mg CTdrug
sildenafil citrate 100 mg CT, single dose with water
Viagra®drug
sildenafil citrate 100 mg film-coated tablet (Viagra®), single dose